Raymond James & Associates Grifols Sa Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
A detailed history of Raymond James & Associates transactions in Grifols Sa stock. As of the latest transaction made, Raymond James & Associates holds 14,952 shares of GRFS stock, worth $94,197. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,952
Previous 10,919
36.94%
Holding current value
$94,197
Previous $126,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding GRFS
# of Institutions
150Shares Held
140MCall Options Held
3.54MPut Options Held
919K-
Capital World Investors Los Angeles, CA20.7MShares$131 Million0.02% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA17.1MShares$108 Million1.53% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny14.4MShares$90.4 Million0.04% of portfolio
-
Permian Investment Partners, LP New York, NY12.8MShares$80.9 Million11.07% of portfolio
-
Black Creek Investment Management Inc. Toronto, A611.5MShares$72.2 Million2.32% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $4.28B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...